Chinese instructions for Bosutinib

1. Indications (Indications):

Bosutinib is mainly suitable for the treatment of chronic myeloid leukemia (Chronic Myeloid Leukemia, CML), especially for patients who are resistant or intolerant to other treatments. The drug helps control the growth and division of leukemia cells by inhibiting the activity of abnormal kinases.

2. Mechanism of Action (Mechanism of Action):

Bosutinib belongs to the second generation of tyrosine kinase inhibitors. Its main function is to inhibit the kinase activity ofBCR-ABL fusion protein. BCR-ABLfusion protein is an abnormal protein in CML patients, causing abnormal proliferation of leukemia cells. By interfering with this kinase activity, bosutinib inhibits the growth and division of leukemia cells.

3. Pharmacology (Pharmacology):

Bosutinib is administered orally and is rapidly absorbed into the body. Its metabolism in the body mainly passes through the liver to form metabolites. The drug has a short half-life in the body and requires multiple divided doses to maintain effective blood concentrations. The drug is eliminated primarily through the urine.

4. Dosage and Administration (Dosage and Administration):

The dosage and usage of bosutinib need to be determined according to the specific situation of the patient, and the doctor will make individual adjustments based on the patient's age, weight, overall health and other factors. Patients should use medications accurately as directed by their doctor and avoid missing doses or overdosing.

5. Side Effects:

Bosutinib may cause some adverse reactions, including but not limited to nausea, vomiting, diarrhea, fatigue, joint pain, etc. During the medication, patients should pay close attention to their physical condition and report any abnormal reactions to their doctor in a timely manner. If serious side effects occur, seek medical attention immediately.

6. Warnings and Precautions (Warnings and Precautions):

When using bosutinib, patients should follow their doctor's recommendations and undergo relevant medical monitoring regularly. Especially for patients with heart problems, liver disease or other serious health problems, special caution is required before use. While using the medication, patients should avoid interactions with certain foods or other medications to ensure the effectiveness of the treatment.

7. Contraindications (Contraindications):

Bosutinib may be contraindicated in certain conditions, such as patients with drug allergies, pregnant or breastfeeding women, etc. Before use, the doctor will conduct a detailed assessment of the patient's medical history to ensure that the patient has no contraindications.

8. Drug Interactions (Drug Interactions):

Patients who are taking bosutinib need to tell their doctors about all the medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Bosutinib may interact with other medications, affecting their efficacy or increasing the risk of side effects.

9. Medicine for special populations (Special Populations):

For special groups, such as elderly patients, patients with abnormal liver function, patients with abnormal renal function, and children, doctors need to adjust the dosage regimen of bosutinib according to individual conditions. During treatment, the patient's physiological indicators need to be monitored regularly to ensure the safety and effectiveness of the drug.

10. Launch and price situation:

Bosutinib is not yet available in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are original drugs and generic drugs of bosutinib abroad. The original drugs include the Turkish original drug and the European version of the original drug. The Turkish version of the original drug costs about 2,000 to 3,000 yuan, and the European version of the original drug costs about 30,000 yuan. In addition, there are cheaper generic drugs, which cost more than one thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

During the use of bosutinib, close communication between patients and doctors is very important. Patients should fully understand the use of the drug and possible risks to ensure the best effect of treatment. At the same time, as medical research continues to advance, it is recommended to obtain the latest medical information in a timely manner.